Dr. Sagar Sardesai, MD
Claim this profileOhio State University Comprehensive Cancer Center
Expert in Breast Cancer
Studies Lobular Carcinoma in Situ
14 reported clinical trials
25 drugs studied
Area of expertise
1Breast Cancer
Global LeaderStage III
HER2 positive
Stage II
2Lobular Carcinoma In Situ
Stage II
Stage I
Stage III
Affiliated Hospitals
Clinical Trials Sagar Sardesai, MD is currently running
Acolbifene vs. Tamoxifen
for Breast Cancer Prevention
This trial is testing two pills, acolbifene and low dose tamoxifen, to prevent breast cancer in premenopausal women at high risk. These women are chosen because they have a much higher chance of developing breast cancer. The drugs work by blocking estrogen, which can help stop the growth of cancer cells. Acolbifene is being assessed for breast cancer prevention, while tamoxifen has been widely studied and used for reducing breast cancer risk.
Recruiting1 award Phase 216 criteria
Denosumab to Prevent Breast Cancer in Women With BRCA1 Mutation
for undefined
This phase III trial compares denosumab to placebo for the prevention of breast cancer in women with a BRCA1 germline mutation. A germline mutation is an inherited gene change which, in the BRCA1 gene, is associated with an increased risk of breast and other cancers. Denosumab is a monoclonal antibody that is used to treat bone loss in order to reduce the risk of bone fractures in healthy people, and to reduce new bone growths in cancer patients whose cancer has spread to their bones. Research has shown that denosumab may also reduce the risk of developing breast cancer in women carrying a BRCA1 germline mutation.
Recruiting1 award Phase 38 criteria
More about Sagar Sardesai, MD
Clinical Trial Related1 year of experience running clinical trials · Led 14 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Sagar Sardesai, MD has experience with
- Fulvestrant
- Paclitaxel
- Tamoxifen
- EMBr Wave
- Pelareorep
- Avelumab
Breakdown of trials Sagar Sardesai, MD has run
Breast Cancer
Lobular Carcinoma in Situ
Cancer
Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sagar Sardesai, MD specialize in?
Sagar Sardesai, MD focuses on Breast Cancer and Lobular Carcinoma in Situ. In particular, much of their work with Breast Cancer has involved Stage III patients, or patients who are HER2 positive.
Is Sagar Sardesai, MD currently recruiting for clinical trials?
Yes, Sagar Sardesai, MD is currently recruiting for 6 clinical trials in Columbus Ohio. If you're interested in participating, you should apply.
Are there any treatments that Sagar Sardesai, MD has studied deeply?
Yes, Sagar Sardesai, MD has studied treatments such as Fulvestrant, Paclitaxel, Tamoxifen.
What is the best way to schedule an appointment with Sagar Sardesai, MD?
Apply for one of the trials that Sagar Sardesai, MD is conducting.
What is the office address of Sagar Sardesai, MD?
The office of Sagar Sardesai, MD is located at: Ohio State University Comprehensive Cancer Center, Columbus, Ohio 43210 United States. This is the address for their practice at the Ohio State University Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.